Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
Monash University is No.1 in the world for pharmacy and pharmacology, but what does that mean, and how are the university rankings calculated?
The new Neuromedicines Discovery Centre (NDC) aims to develop psychiatric drugs and approaches to psychedelic-assisted psychotherapies for common mental illnesses.
Researchers are exploring the medical frontier of psychedelics, and their use in facilitating psychotherapy for common mental illnesses.
Could psychedelic drugs provide the next big breakthrough in psychiatry? This episode of the ‘What Happens Next?’ podcast considers the regulatory, cultural and scientific aspects of psychedelic treatment for mental illness – and how innovation in this area could improve the lives of millions of people.
A research project aims to boost pharmacists’ roles in neighbourhood mental health.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
Researchers are delving into a protein with the potential to stop habitual drinking.
Two Monash students – and also firm friends – are on a mission to boost the uptake of the influenza vaccine.
A young pharmacist with a keen sense of legacy is working at the forefront of medicine management.
Doctors rely on independent guidelines when prescribing medication – and Mary Hemming AO is a key figure behind these.
Our experts provide tips and information for those who want to better understand and embrace the idea of planetary health.
How has COVID-19 accelerated technological change, innovation and advancement in digital healthcare?
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
The trumpeting of hydroxychloroquine's potential in treating COVID-19 raises ethical and safety concerns.
A new advocacy group aims to address gender imbalance in science by helping map the career trajectories of early-to-mid-career researchers through promotion of their existing research achievements.
Thomas Ko is spearheading innovative technology that takes injectable medicines and transforms them into pills.
Promoting excellence in pharmacy teaching will impact the healthcare of communities for years to come.
Opioids are among the most powerful analgesics available to medicine, but they have huge capacity to cause harm. In trying to solve one problem, is a bigger one being created?
The drug epidemic that's claimed thousands of lives in the US is swiftly becoming a threat to the health of many Australians.
Pharmacy students will be trained to improve the online encyclopaedia as an educational resource by ensuring its pages are kept up to date with accurate information.
Instead of killing the disease – as chemotherapy and radiotherapy do – a new and “lateral” approach to treatment shows great promise.
Dummy text
